hepatitis C

Hepatitis C In Play for 2013?
Motley Fool
Wed, 02/27/13 - 11:24 am
hepatitis C
BMS-986094
Bristol-Myers Squibb
Gilead
Idenix
Incivek
Achillion
Vertex Pharmaceuticals
Regulators Await Gilead's Hep C Candidate
Seeking Alpha
Thu, 02/21/13 - 06:39 pm
Gilead
hepatitis C
sofosbuvir
Gilead hepatitis C drug meets goal of 4th late-stage study
Reuters
Tue, 02/19/13 - 03:24 pm
hepatitis C
Gilead
sofosbuvir
Idenix Pharma ends development of 2 hepatitis C drugs after regulators signal further holds
Yahoo/AP
Tue, 02/5/13 - 10:38 am
Idenix
hepatitis C
IDX184
IDX19368
Gilead's 2 hepatitis C drug trials meet study goals
Reuters
Mon, 02/4/13 - 12:17 pm
Gilead
hepatitis C
Neutrino
Fission
Bristol-Myers Tries To Settle Hep C Patient Claims
Pharmalot
Wed, 01/16/13 - 08:16 am
hepatitis C
Bristol-Myers Squibb
Idenix May Drop Delayed Hepatitis C Drug for New Versions
Bloomberg
Thu, 01/10/13 - 09:02 am
Idenix
hepatitis C
IDX-184
IDX-19368
2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
HCV
Vertex Pharmaceuticals
Merck
Gilead Sciences
Abbott Laboratories
hepatitis C
Achillion
Idenix
JNJ
GSK
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
hepatitis C
Vertex Pharmaceuticals
Gilead
Merck
Abbott Labs
Achillion
GSK
JNJ
Idenix
Bristol-Myers Squibb
Vertex strengthens warning with hepatitis C drug
Reuters
Wed, 12/19/12 - 01:31 pm
Vertex
hepatitis C
Incivek
Gilead, Abbott should benefit from first mover HCV advantage, says Wells Fargo
Yahoo/Fly on the Wall
Mon, 12/17/12 - 01:13 pm
Gilead
Abbott Labs
hepatitis C
Invest in the Great Progress of Hepatitis C
Motley Fool
Sat, 12/8/12 - 11:17 am
hepatitis C
Gilead Sciences
sofosbuvir
Medivir
TMC435
ACH-1625
Achillion
Gilead Sciences Leads The Race In Developing A Hepatitis C Pill
Seeking Alpha
Sat, 12/8/12 - 11:04 am
Gilead Sciences
hepatitis C
sofosbuvir
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Fri, 11/30/12 - 12:10 pm
hepatitis C
Achillion
Gilead
Idenix
Merck
Medivir
Vertex Pharmaceuticals
Gilead Sciences Scores First Win With Late-Stage Hep C Study
TheStreet.com
Tue, 11/27/12 - 10:30 am
hepatitis C
Gilead
sofosbuvir
5 Drug Hopefuls That Are Going to Change Your Life: Part 2
Motley Fool
Sat, 11/24/12 - 12:01 pm
Gilead Sciences
sofosbuvir
hepatitis C
Bristol-Myers Squibb
BMS-986094
Idenix
IDX-184
Abbott Laboratories
Achillion
ACH-3102
FDA Approval Victory a Yawner?
Motley Fool
Tue, 11/20/12 - 11:24 am
FDA
GSK
Ligand
Promacta
hepatitis C
This Week in Biotech: Part 1 (The Hep-C Chronicles)
Motley Fool
Sat, 11/17/12 - 01:47 pm
Gilead Sciences
Abbott Laboratories
Idenix
Achillion
hepatitis C
All Is Well That Ends Well; Acquisition By Gilead Sciences Pays Off
Seeking Alpha
Wed, 11/14/12 - 12:32 pm
Gilead
M&A
hepatitis C
Does Achillion Have a Place in the HCV Market of the Future?
Yahoo/Reuters
Wed, 11/14/12 - 12:30 pm
Achillion
hepatitis C
Abbott Labs
Gilead
ACH-1625
Vertex Pharmaceuticals

Pages